BackChiasma Overview

Chiasma Total Assets

Track Chiasma's total assets ($160M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$159.53M
↑ 83.96% YoYΔ $72.81M vs prior year quarter

Peer average

Loading

Chiasma Total Assets History

Loading

Chiasma vs. peers: Total Assets Comparison

Loading

Chiasma Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Chiasma (CHMA) FAQ

Chiasma (CHMA) currently reports a total assets of $160M as of March 2021. That compares with $87M in the prior-year period — up 84.0% year over year. Use the charts on this page to explore Chiasma's total assets history and peer comparisons.

Chiasma's total assets increased from $87M to $160M — a 84.0% year-over-year increase (period ending March 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Chiasma reported $160M in total assets as of March 2021. That compares with $87M in the prior-year period — up 84.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $160M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Chiasma, and consider following CHMA for alerts when major investors trade the stock.

Chiasma is classified in the Healthcare sector. On total assets, it currently shows $160M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CHMA with unrelated industries.